[1] |
GBD DALYs, and HALE Collaborators. Global,regional,and national disability-adjusted life-years(DALYs) for 359 diseases and injuries and healthy life expectancy(HALE) for 195 countries and territories,1990-2017:a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2018, 392(10159):1859-1922.
DOI
URL
|
[2] |
WHO. Projections of mortality and causes of death,2016 and 2060[EB/OL].(2019-10-14)[2021-09-27]. https://www.who.inthealthinfo/global_burden_disease/projections/en/.
|
[3] |
Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China(the China Pulmonary Health[CPH] study):a national cross-sectional study[J]. Lancet, 2018, 391(10131):1706-1717.
DOI
URL
|
[4] |
Ejiofor SI, Stolk J, Fernandez P, et al. Patterns and characterization of COPD exacerbations using real-time data collection[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12:427-434.
DOI
URL
|
[5] |
Carvalho-Jr LCS, Trimer R, Arêas GP, et al. COPD assessment test and FEV1:do they predict oxygen uptake in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2018, 13:3149-3156.
DOI
URL
|
[6] |
US Department of Health and Human Services FDA Center for Drug Evaluation and Research, US Department of Health and Human Services FDA Center for Biologics Evaluation and Research, US Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry:patient-reported outcome measures:use in medical product development to support labeling claims:draft guidance[J]. Health Qual Life Outcomes, 2006, 4:79.
DOI
URL
|
[7] |
Kluetz PG, O’Connor DJ, Soltys K. Incorporating the patient experience into regulatory decision making in the USA,Europe,and Canada[J]. Lancet Oncol, 2018, 19(5):e267-e274.
DOI
URL
|
[8] |
Global Initiative for Chronic Lung Disease (GOLD) . Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2020 report[EB/OL]. (2019-11-05) [2021-10-06]. https://goldCOPD.org/gold-reports/.
|
[9] |
杨苏, 黄丽华. 患者自我报告结局在慢性阻塞性肺疾病患者中的应用进展[J]. 中华护理杂志, 2020, 55(5):716-720.
|
|
Yang S, Huang LH. Progress on the application of self-reported outcome measures in patients with chronic obstructive pulmonary disease[J]. Chin J Nurs, 2020, 55(5):716-720.
|
[10] |
倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计[J]. 中华护理杂志, 2010, 45(4):378-380.
|
|
Ni P, Chen JL, Liu N. The sample size estimation in quantitative nursing research[J]. Chin J Nurs, 2010, 45(4):378-380.
|
[11] |
Li JS, Wang JJ, Xie Y, et al. Development and validation of the Modified Patient-Reported Outcome Scale for Chronic Obstructive Pulmonary Disease(mCOPD-PRO)[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15:661-669.
DOI
URL
|
[12] |
Lim KE, Kim SR, Kim HK, et al. Symptom clusters and quality of life in subjects with COPD[J]. Respir Care, 2017, 62(9):1203-1211.
DOI
URL
|
[13] |
Trivedi D. Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease[J]. Prim Health Care Res Dev, 2020, 21:e41.
DOI
URL
|
[14] |
Hodson M, Roberts CM, Andrew S, et al. Development and first validation of a patient-reported experience measure in chronic obstructive pulmonary disease(PREM-C9)[J]. Thorax, 2019, 74(6):600-603.
DOI
URL
|
[15] |
Ekström M, Sundh J, Larsson K. Patient reported outcome measures in chronic obstructive pulmonary disease:which to use[J]. Expert Rev Respir Med, 2016, 10(3):351-362.
DOI
URL
|
[16] |
Han MK. Chronic obstructive pulmonary disease in women:a biologically focused review with a systematic search strategy[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15:711-721.
DOI
URL
|
[17] |
Christensen VL, Rustøen T, Cooper BA, et al. Distinct symptom experiences in subgroups of patients with COPD[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11:1801-1809.
DOI
URL
|
[18] |
刘林霞, 曾玉琴, 刘祁汨, 等. 女性慢性阻塞性肺疾病的临床特点[J]. 中国医师杂志, 2020, 22(10):1461-1463,1467.
|
|
Liu LX, Zeng YQ, Liu QM, et al. Clinical features of chronic obstructive pulmonary disease in women[J]. J Chin Physician, 2020, 22(10):1461-1463,1467.
|
[19] |
Perez TA, Castillo EG, Ancochea J, et al. Sex differences between women and men with COPD:a new analysis of the 3CIA study[J]. Respir Med, 2020, 171:106105.
|
[20] |
Gut-Gobert C, Cavaillès A, Dixmier A, et al. Women and COPD:do we need more evidence[J]. Eur Respir Rev, 2019, 28(151):180055.
|
[21] |
张倩, 李晶华, 马天娇, 等. Charlson合并症指数对COPD患者住院时间、住院费用及院内死亡的影响[J]. 医学与社会, 2021, 34(8):73-78.
|
|
Zhang Q, Li JH, Ma TJ, et al. The influence of Charlson comorbidity index on length of stay,cost of hospitalization and in-hospital death in patients with COPD[J]. Med Soc, 2021, 34(8):73-78.
|
[22] |
Frent SM, Chapman KR, Larbig M, et al. Capturing exacerbations of chronic obstructive pulmonary disease with EXACT. A subanalysis of FLAME[J]. Am J Respir Crit Care Med, 2019, 199(1):43-51.
DOI
URL
|
[23] |
娄正磊, 袁茹. 老年慢性阻塞性肺疾病患者心理社会适应水平及影响因素[J]. 中国健康心理学杂志, 2021, 29(6):835-838.
|
|
Lou ZL, Yuan R. Psychosocial adaptation level and its influencing factors of elderly patients with COPD[J]. China J Heal Psychol, 2021, 29(6):835-838.
|
[24] |
Jones PW, Donohue JF, Nedelman J, et al. Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease:a pooled analysis[J]. Respir Res, 2011, 12:161.
DOI
URL
|
[25] |
Donohue JF, Jones PW, Bartels C, et al. Correlations between FEV1 and patient-reported outcomes:a pooled analysis of 23 clinical trials in patients with chronic obstructive pulmonary disease[J]. Pulm Pharmacol Ther, 2018, 49:11-19.
DOI
PMID
|
[26] |
张义静, 李娟, 孙丽, 等. 慢性阻塞性肺疾病患者早期简易肺康复方案的构建及应用[J]. 中华护理杂志, 2020, 55(5):690-695.
|
|
Zhang YJ, Li J, Sun L, et al. Construction of an early simple pulmonary rehabilitation program for patients with COPD and its evaluation of effectiveness[J]. Chin J Nurs, 2020, 55(5):690-695.
|
[27] |
胡磊, 张大卫, 江浩洋, 等. 慢性阻塞性肺疾病患者系统性炎症水平与肺气肿程度和骨密度改变相关性研究[J]. 中华结核和呼吸杂志, 2021, 44(3):213-217.
|
|
Hu L, Zhang DW, Jiang HY, et al. Correlation between systemic inflammation level and emphysema degree and bone mineral density in chronic obstructive pulmonary disease patients and its mechanism[J]. Chin J Tuberc Respir Dis, 2021, 44(3):213-217.
|
[28] |
Tian W, Jiang XG, Kim D, et al. Leukotrienes in tumor-associated inflammation[J]. Front Pharmacol, 2020, 11:1289.
DOI
PMID
|
[29] |
McKeever TM, Hearson G, Housley G, et al. Using venous blood gas analysis in the assessment of COPD exacerbations:a prospective cohort study[J]. Thorax, 2016, 71(3):210-215.
DOI
PMID
|
[30] |
Müllerová H, Hahn B, Simard EP, et al. Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts[J]. Int J Chron Obstruct Pulmon Dis, 2019, 14:683-692.
DOI
URL
|
[31] |
Wright TK, Gibson PG, Simpson JL, et al. Neutrophil extracellular traps are associated with inflammation in chronic airway disease[J]. Respirology, 2016, 21(3):467-475.
DOI
URL
|
[32] |
王赛男. 血清白蛋白与球蛋白比值在慢性阻塞性肺疾病急性加重患者中的临床意义[D]. 郑州:郑州大学, 2020.
|
|
Wang SN. Clinical significance of serum albumin to globulin ratio in patients with acute exacerbation of chronic obstructive pulmonary disease[D]. Zhengzhou:Zhengzhou University, 2020.
|
[33] |
Upadhyay K, Uniyal A, Guleria R, et al. Serum prealbumin is a useful marker of inflammation and monitoring tool in patients with AECOPD[J]. Chest, 2013, 144(4):88.
|
[34] |
谢梅, 刘春红, 刘艳琴. 老年慢性阻塞性肺疾病住院病人的营养水平及肺功能分析[J]. 实用老年医学, 2019, 33(10):1012-1015.
|
|
Xie M, Liu CH, Liu YQ. Nutritional status and lung function in elderly inpatients with chronic obstructive pulmonary disease[J]. Pract Geriatr, 2019, 33(10):1012-1015.
|